Vesna Olsson

Vesna Olsson is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as a Senior Regulatory Affairs Manager at PolyPeptide Group since August 2018, Vesna leads CMC regulatory strategies, compliance, and documentation for development projects and manages the life cycle of commercial and generic drug substances. Previously, Vesna held roles as a Regulatory Affairs Manager at Natumin Pharma AB, where responsibilities included implementing regulatory strategies for natural remedies and traditional herbal medicines, and as a Senior CMC Documentation Coordinator at AstraZeneca R&D, overseeing CMC documentation for major regulatory submissions and clinical projects. Vesna began a career in analytical development with experience as a Research Technician. Education was completed at Lund University, earning an MSc in Chemistry.